News

Filter

Current filters:

None

28 to 37 of 96663 results

Gilead third-qtr sales beat expectations, but Sovaldi disappoints

Gilead third-qtr sales beat expectations, but Sovaldi disappoints

29-10-2014

There was mixed news late yesterday from US anti-virals major Gilead Sciences, when the biotech posted…

Anti-viralsBiotechnologyFinancialGilead SciencesHarvoniSovaldiUSA

Sanofi ousts CEO Viehbacher, despite recent denials

Sanofi ousts CEO Viehbacher, despite recent denials

29-10-2014

Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion,…

BoardroomFranceManagementPharmaceuticalSanofi

Pfizer beats sales and earnings forecast for the third quarter

Pfizer beats sales and earnings forecast for the third quarter

28-10-2014

US pharma giant Pfizer has beaten the forecasts for both its sales and its earnings for the third quarter…

FinancialLyricaPfizerPharmaceuticalUSAViagra

Bristol-Myers enters option deal to acquire F-star Alpha and FS102

28-10-2014

US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

Recordati reports strong earnings growth for first nine months of 2014

28-10-2014

Italian pharma company Recordati has reported a strong set of financials for the first three-quarters…

FinancialPharmaceuticalRecordati

Russian approval for Norgine/Takeda’s MoviPrep

28-10-2014

Netherlands-headquartered independent drugmaker Norgine says that its partner, Japan’s largest pharma…

Gastro-intestinalsMoviPrepNorginePharmaceuticalRegulationRussiaTakeda Pharmaceutical

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

28-10-2014

Rare and infectious disease specialist Sarepta provided an update on its discussions with the US Food…

CNS DiseaseseteplirsenPharmaceuticalRegulationSarepta TherapeuticsUSA

Bristol-Myers Squibb signs deal with Korean company OliPass

Bristol-Myers Squibb signs deal with Korean company OliPass

28-10-2014

Privately-held Korean biopharmaceutical company OliPass has announced a worldwide strategic alliance…

Bristol-Myers SquibbOliPassPharmaceuticalResearchRest of the World

Elderly UK patients with rare blood cancer receive substandard care

Elderly UK patients with rare blood cancer receive substandard care

28-10-2014

Elderly people in the UK with Myelodysplastic Syndromes (MDS), a rare form of blood cancer, are not being…

Celgene Corp.HealthcareOncologyPharmaceuticalResearchUK

28 to 37 of 96663 results

Parexel

Parexel

Back to top